By proceeding, you agree to our Terms of Use and Privacy Policy.
Over 300 attendees representing internationally renowned academic organisations & research institutes as well as global pharmaceutical organisations, leading biotech companiesOver 20 case studies, presentations, panel discussions focused on the key issues in inhaled therapies formulation, delivery and moving towards sustainable device developmentMaximise your event experience with exclusive interactive programme features such as workshops, panel discussions and roundtables, tapping into the priorities & challenges of the wider sequencing & clinical genomics market
Gain insights from industry experts, network with peers, and discover innovative solutions.
Expand your inhalation formulation and delivery knowledge through interactive presentations, workshops, and case studies into the latest regulatory updates.
Engage with experts, participate in panel discussions, and connect with like-minded professionals. Experience firsthand the power of shared experiences.
Discover new possibilities, emerging technologies, and disruptive approaches that will shape the future of inhalation formulation and delivery.
Oxford Global exists to accelerate progress in the healthcare and pharma industry by connecting the right people around the most important issues.
A unique culture delivering exceptional solutions: Almac is a financially secure, privately owned organisation with over 6,000 employees located within the US, Europe and Asia. 600+ companies worldwide, including all the market leaders, use ou
BioDuro-Sundia is a global provider of contract research, development and manufacturing outsourcing solutions.
At Lonza, we enable #AHealthierWorld by supporting our healthcare customers on the path to commercialization.
Our team combines leading expertise in the manufacture and applications of vitamin E TPGS and product formulation.
Celanese is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications.
About Recipharm: Recipharm is a leading contract development and manufacturing organisation (CDMO) headquartered in Stockholm, Sweden.
RedShiftBio is redefining the possibilities for structural characterization of biomolecules.
Sever Pharma Solutions brings your pharmaceutical ideas to life by offering expertise in high potent drug development, a drive to enhance performance, a passion for perfection, and a commitment to be your partner through the whole journey.
We are a quantum physics-based, AI-powered drug R&D company with the mission to revolutionize drug discovery and development by improving the speed, scale, novelty and success rate. With operations in both China and the U.S., we strive to deploy the
We are a quantum physics-based, AI-powered drug R&D company with the mission to revolutionize drug discovery and development by improving the speed, scale, novelty and success rate. With operations in both China and the U.S., we strive to deploy the best capabilities and resources available to us in
Proveris helps pharmaceutical companies developing orally inhaled and nasal drug products (OINDPs) reach the market sooner, saving significant time and money.Proveris believes that developing effective OINDP products requires in-depth knowled
Proveris helps pharmaceutical companies developing orally inhaled and nasal drug products (OINDPs) reach the market sooner, saving significant time and money.Proveris believes that developing effective OINDP products requires in-depth knowledge and expertise to understand and control the com
Erbi Biosystems is revolutionizing cell therapy and bioprocessing process development with the Breez™, a fully automated 2 mL TruePerfusion™ bioreactor. Scarce and expensive raw materials no longer restrict generation of process development data enab
Erbi Biosystems is revolutionizing cell therapy and bioprocessing process development with the Breez™, a fully automated 2 mL TruePerfusion™ bioreactor. Scarce and expensive raw materials no longer restrict generation of process development data enabling improved CMC. A single 2mL volume cassette c
Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to maximize safety and optimize interaction to improve the solubility, stability, bioavailability or lessen volatility, irritation, smel
Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to maximize safety and optimize interaction to improve the solubility, stability, bioavailability or lessen volatility, irritation, smell or taste. Captisol® is a polyanionic beta-cyclod
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.